NanoXplore's U.S. Subsidiary Enters Into a Consent Order With U.S. EPA

NanoXplore Inc. (" NanoXplore " or the " Corporation ") (TSX: GRA and OTCQX: NNXPF) announces that on August 13, 2021, its U.S. subsidiary RMC Advanced Technologies Inc. entered into a consent order with the U.S. Environmental Protection Agency (" EPA ") under the Toxic Substances Control Act (TSCA) (the " Consent Order "), which Consent Order allows for the commercial use of its GrapheneBlack TM as an additive for thermoplastics, thermosets and rubbers, with no annual volume limitation.

Soroush Nazarpour, President and Chief Executive Officer of NanoXplore, commented:

"This long-awaited news constitutes a significant milestone for NanoXplore, as it opens the GrapheneBlack TM market in the U.S. It marks a historic year for us: Eleven years after graphene winning the Nobel Prize, NanoXplore's graphene reaches regulatory approval for industrial volumes in the U.S."

About NanoXplore Inc.

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in industrial markets. The Corporation provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities in Canada, the United States and Europe.

For more information, please contact:

Soroush Nazarpour
President and Chief Executive Officer
NanoXplore Inc.
(514) 935-1377
info@NanoXplore.ca


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this... Keep Reading...
Vaxcyte Inc.

Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Keep Reading...
G6 Materials

G6 Materials

OverviewG6 Materials Corp. (TSXV:GGG,OTCQB:GPHBF) provides high-tech graphene solutions for a variety of commercial, research and military applications at low costs. Through the company’s wholly-owned subsidiary, Graphene Laboratories Inc., G6 Materials currently offers over 100 graphene and... Keep Reading...
G6 Materials Corp Closes $1,001,000 Private Placement

G6 Materials Corp Closes $1,001,000 Private Placement

G6 Materials Corp. (TSXV:GGG) (OTC:GPHBF) (the “Company” or “G6”) is pleased to announce that it has closed a non-brokered private placement and issued 14,300,001 units at a price of $0.07 per unit to raise aggregate proceeds of $1,001,000.07. Each unit consists of one common share and one... Keep Reading...
G6 Materials Corp. Announces Upsize of Private Placement to Raise $1,001,000

G6 Materials Corp. Announces Upsize of Private Placement to Raise $1,001,000

G6 Materials Corp. (the “Company” or “G6”) (TSXV:GGG) (OTC:GPHBF) is pleased to announce its intention to increase the size of its previously announced non-brokered private placement from C$350,000 to $1,001,000. The Company will issue up to 14,300,000 Units for total gross proceeds of up to... Keep Reading...
G6 Materials Corp. Develops Disinfection Products to Fight the Spread of COVID-19

G6 Materials Corp. Develops Disinfection Products to Fight the Spread of COVID-19

G6 Materials Corp. (the “Company” or “G6”) (TSXV:GGG) (OTC:GPHBF) is pleased to provide an update from its Research & Development department. The outbreak of the COVID-19 has drastically altered the economic landscape, and G6 management is optimizing the business model to accommodate the new... Keep Reading...

Interactive Chart

Latest Press Releases

Related News